Use of Oseltamivir to control influenza complications after bone marrow transplantation

Bone Marrow Transplantation

Volumn 34, Issue 2, 2004, Pages 111-114

  Machado, C M ^a,b   Boas, L S V ^a   Mendes, A V A ^a   da Rocha, I F ^a   Sturaro, D ^a   Dulley, F L ^a   Pannuti, C S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Univ of Sao Paulo Medical School ^*  (Brazil)

Author keywords

BMT; Influenza; Oseltamivir; Pneumonia; Respiratory virus

Indexed keywords

AMANTADINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLUENZA VACCINE; MELPHALAN; OSELTAMIVIR; PREDNISONE; SIALIDASE INHIBITOR;

ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DRUG SAFETY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; NOSE SMEAR; POPULATION RESEARCH; PRIORITY JOURNAL; SIDE EFFECT; SPRING; SUMMER; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ACETAMIDES; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INFLUENZAVIRUS B; NASAL LAVAGE FLUID; OSELTAMIVIR; PREMEDICATION; SEASONS; TREATMENT OUTCOME;

EID: 4043056504     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704534     Document Type: Article

References (14)

1. Whimbey E, Elting LS, Cough RB et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437-440.
2. Bowden RA. Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center experience. Am J Med 1997; 102: 27-30.
3. Cough RB, Englund JA, Whimbley E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102: 2-9.
4. Ljungman P, Ward KN, Crooks BNA et al. Respiratory virus infection after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484.
5. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 2001; 28: 775-781.
6. Gandhi MK, Egner W, Sizer L et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 1993; 11: 1-5.
7. Machado CM, Vilas Boas LS, Mendes AVA et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 695-700.
8. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs 2001; 61: 263-283.
9. Englund JA, Piedra PA, Jewell A et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 1996; 34: 1649-1653.
10. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev 2003; 4: 105-111.
11. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. JAMA 2000; 283: 1016-1024.
12. Dykewicz CA, Jaffe HW, Kaplan JE. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morbidity Mortality Weekly Rep 2000; 49 (RR-10): 1-128.
13. Pauksen K, Linde A, Hammarstrom V et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30: 342-348.
14. Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor Oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282: 1240-1246.